Bangladesh LOINC Answer Lists ValueSet - Bangladesh Core FHIR Implementation Guide v0.5.0

Bangladesh Core FHIR Implementation Guide - Published by Ministry of Health and Family Welfare. See the Directory of published versions

ValueSet: Bangladesh LOINC Answer Lists ValueSet (Experimental)

Official URL: https://fhir.dghs.gov.bd/core/ValueSet/bd-loinc-answer-lists-valueset				Version: 0.5.0
Standards status: Informative				Computable Name: BDLoincAnswerListsVS
Copyright/Legal: This content from LOINC® is copyright © 1995 Regenstrief Institute, Inc. and the LOINC Committee, and available at no cost under the license at http://loinc.org/terms-of-use.

LOINC answer codes (LA-prefixed, property Answer) and answer lists (LL-prefixed, property AnswerList) for coded laboratory results. Used as Observation.valueCodeableConcept in bd-lab-result-observation for ordinal and nominal scale results.

This value set is the guide's broad definition. It is expressed with LOINC filters, so no codes are enumerated here. The curated national list is the value set loinc-answer-lists on the national terminology server, which enforces membership at runtime through $validate-code. Bindings to this value set are extensible.

References

Bangladesh Laboratory Result Observation

Logical Definition (CLD)

This value set includes codes based on the following rules:

Include codes fromhttp://loinc.org version Not Stated (use latest from terminology server) where Answer exists
Include codes fromhttp://loinc.org version Not Stated (use latest from terminology server) where AnswerList exists

Expansion

Expansion from tx.fhir.org based on Loinc v2.82

This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown

System	Code	Display (en)	JSON	XML
`http://loinc.org`	LL1000-0	PhenX05_13_30D bread amt
`http://loinc.org`	LL1001-8	PhenX05_14_30D freq amts
`http://loinc.org`	LL1002-6	PhenX05_15_30D cereal amt
`http://loinc.org`	LL1003-4	PhenX05_16_beverage amts
`http://loinc.org`	LL1004-2	PhenX05_17_serving size
`http://loinc.org`	LL1005-9	PhenX05_18_dietary supplements
`http://loinc.org`	LL1006-7	PhenX05_19_vitamin freq
`http://loinc.org`	LL1007-5	PhenX05_20_Ys vitamin use
`http://loinc.org`	LL1008-3	PhenX05_21_vit C amt
`http://loinc.org`	LL100-9	CR_1430_Reason no radiation
`http://loinc.org`	LL1009-1	PhenX05_22_vit E amt
`http://loinc.org`	LL1010-9	PhenX05_23_food freq
`http://loinc.org`	LL1011-7	PhenX05_24_margarine freq
`http://loinc.org`	LL1012-5	[PROMIS] Excellent\|Very good\|Good\|Fair\|Poor
`http://loinc.org`	LL1013-3	[PROMIS] Completely\|Mostly\|Mod\|A little\|Not at all
`http://loinc.org`	LL1014-1	[PROMIS] 0-no pain\|1\|2\|3\|4\|5\|6\|7\|8\|9\|10-worst imag
`http://loinc.org`	LL1015-8	[PROMIS] None\|Mild\|Moderate\|Severe\|Very severe
`http://loinc.org`	LL1016-6	[PROMIS] Never\|Rarely\|Sometimes\|Often\|Always
`http://loinc.org`	LL101-7	CR_1440_Reason no chemo
`http://loinc.org`	LL1017-4	[PROMIS] Not at all\|Lit bit\|Somwh\|Qte bit\|Ver much
`http://loinc.org`	LL1018-2	[PROMIS] None\|1 day\|2-3 days\|4-5 days\|6-7 days
`http://loinc.org`	LL1019-0	[PROMIS] Had no pain\|Nev\|Rare\|Sometim\|Oft\|Alw
`http://loinc.org`	LL1020-8	[PROMIS] Never\|<=1/W\|1/few days\|1/D\|Every few H
`http://loinc.org`	LL1021-6	[PROMIS] Not at all\|Ver litt\|Some\|Qte lot\|Can't do
`http://loinc.org`	LL1022-4	[PROMIS] Diffic: WO\|W lit\|W some\|W much\|Unab to do
`http://loinc.org`	LL1023-2	[PROMIS] Very poor\|Poor\|Fair\|Good\|Very good
`http://loinc.org`	LL1024-0	[PROMIS] Nev\|Alm never\|Sometimes\|Often\|Alm always
`http://loinc.org`	LL102-5	CR_1450_Reason no hormones
`http://loinc.org`	LL1025-7	[PROMIS] W no troub\|Lit tr\|Some tr\|Lot tr\|Not able
`http://loinc.org`	LL1026-5	[PROMIS] Diffic:No\|A lit\|Some\|Lot\|Can't do bc hlth
`http://loinc.org`	LL1027-3	PhenX05_25_30D cereal freq
`http://loinc.org`	LL1028-1	PhenX05_26_30D calcium OJ freq
`http://loinc.org`	LL1029-9	PhenX05_27_30D ice cream amt
`http://loinc.org`	LL1030-7	PhenX05_28_12Mo fat amt
`http://loinc.org`	LL1031-5	PCR_HK
`http://loinc.org`	LL1032-3	Cpenase
`http://loinc.org`	LL103-3	CR_1460_Coding system
`http://loinc.org`	LL1034-9	Normal\|Abnormal\|Clinical significance unknown
`http://loinc.org`	LL1035-6	ISCN band lvl
`http://loinc.org`	LL1036-4	Banding
`http://loinc.org`	LL1037-2	Genetic recommendation
`http://loinc.org`	LL1038-0	Phase
`http://loinc.org`	LL1039-8	HumanReferenceSeqAssembly
`http://loinc.org`	LL1040-6	HumanRefSeqNCBIBuildId
`http://loinc.org`	LL104-1	CR_1470_Protocol eligibility
`http://loinc.org`	LL1041-4	CopyNumberChangeType
`http://loinc.org`	LL1043-0	LDS
`http://loinc.org`	LL1044-8	PhenX01_01_race
`http://loinc.org`	LL1045-5	PhenX01_02_hispanic origin
`http://loinc.org`	LL1047-1	Days\|Months\|Weeks
`http://loinc.org`	LL1048-9	Days\|Months\|Weeks\|Quarter\|As needed
`http://loinc.org`	LL1049-7	Completion
`http://loinc.org`	LL1051-3	Inj Location
`http://loinc.org`	LL1052-1	Injury intent
`http://loinc.org`	LL1053-9	ED dispo
`http://loinc.org`	LL1054-7	SWA
`http://loinc.org`	LL1055-4	Detected\|Not det\|Equiv\|Inconcl\|Spec unsat for eval
`http://loinc.org`	LL1056-2	Bordetella
`http://loinc.org`	LL1057-0	Stable\|Unstable\|Indeterminate
`http://loinc.org`	LL105-8	CR_1480_Protocol source
`http://loinc.org`	LL1058-8	MPL ID'd
`http://loinc.org`	LL1059-6	MPL mut
`http://loinc.org`	LL1061-2	Carbapenemase
`http://loinc.org`	LL1063-8	PIK3CA
`http://loinc.org`	LL1064-6	JAK2 exon12
`http://loinc.org`	LL106-6	CR_1490_Support referral
`http://loinc.org`	LL1066-1	PhenX01_03_birthplace
`http://loinc.org`	LL1067-9	PhenX01_04_relative birthplace
`http://loinc.org`	LL1068-7	PhenX01_05_marital status
`http://loinc.org`	LL1069-5	PhenX01_06_education
`http://loinc.org`	LL1070-3	PhenX01_07_family income 50k
`http://loinc.org`	LL1071-1	PhenX01_08_family income 35k
`http://loinc.org`	LL1072-9	PhenX01_09_family income poverty
`http://loinc.org`	LL1073-7	PhenX01_10_family income 100k
`http://loinc.org`	LL1074-5	PhenX01_11_family income 75k
`http://loinc.org`	LL1075-2	PhenX01_12_relative smoking
`http://loinc.org`	LL1076-0	PhenX01_13_health insurance
`http://loinc.org`	LL1078-6	PhenX06_01_dwelling type
`http://loinc.org`	LL1079-4	PhenX06_02_ house AC type
`http://loinc.org`	LL1080-2	PhenX06_03_months
`http://loinc.org`	LL1081-0	PhenX06_04_heating fuel
`http://loinc.org`	LL108-2	CR_1500_Calculation method
`http://loinc.org`	LL1082-8	PhenX06_05_house pet type
`http://loinc.org`	LL1083-6	PhenX06_06_drinking water source
`http://loinc.org`	LL1084-4	PhenX06_07_well depth
`http://loinc.org`	LL1085-1	PhenX06_08_well cased
`http://loinc.org`	LL1086-9	PhenX06_09_water treatment
`http://loinc.org`	LL1087-7	PhenX06_10_res water supply
`http://loinc.org`	LL1088-5	PhenX06_11_farm
`http://loinc.org`	LL1089-3	PhenX06_12_res location
`http://loinc.org`	LL109-0	CR_1510_Radiation dose
`http://loinc.org`	LL1091-9	PhenX06_14_job hx
`http://loinc.org`	LL1092-7	PhenX06_15_fulltime job hx
`http://loinc.org`	LL1093-5	PhenX06_16_job hx industry
`http://loinc.org`	LL1096-8	PhenX06_19_twin type
`http://loinc.org`	LL1098-4	PhenX06_21_living sibling
`http://loinc.org`	LL1100-8	PhenX06_23_where car parked
`http://loinc.org`	LL1101-6	PhenX06_24_sunburn skin reaction
`http://loinc.org`	LL1102-4	PhenX06_25_age of exposure
`http://loinc.org`	LL1103-2	PhenX06_26_Hs in sun
`http://loinc.org`	LL1104-0	PhenX06_27_workspace renovation
`http://loinc.org`	LL1106-5	PhenX06_28_workspace floor material
`http://loinc.org`	LL1107-3	PhenX06_29_material on wall surface
`http://loinc.org`	LL110-8	CR_1520_No. radiation treatments
`http://loinc.org`	LL1108-1	PhenX06_30_home repairs
`http://loinc.org`	LL1109-9	PhenX06_31_flooring amt
`http://loinc.org`	LL1110-7	PhenX07_01
`http://loinc.org`	LL1111-5	PhenX07_02_drinking weekly age range
`http://loinc.org`	LL1112-3	PhenX07_03_premarin doses
`http://loinc.org`	LL1114-9	PhenX07_05_lung cancer worry
`http://loinc.org`	LL1115-6	PhenX07_06_lung CA risk
`http://loinc.org`	LL111-6	CR_1530_Radiation duration
`http://loinc.org`	LL1116-4	PhenX07_07_conditions associated with cancer
`http://loinc.org`	LL1117-2	PhenX07_08_gallstone dx method
`http://loinc.org`	LL1118-0	PhenX07_09_Ca screening testing
`http://loinc.org`	LL1119-8	PhenX07_10_consider smoking cessation
`http://loinc.org`	LL1120-6	PhenX07_11_longest time smoking cessation
`http://loinc.org`	LL1121-4	PhenX07_12_smoke cessation products
`http://loinc.org`	LL1122-2	PhenX07_13_smoke cessation advice
`http://loinc.org`	LL1123-0	PhenX07_14_laterality
`http://loinc.org`	LL112-4	CR_1540_Radiation target
`http://loinc.org`	LL1125-5	PhenX07_16_chemo drugs
`http://loinc.org`	LL1126-3	PhenX07_17_hormone therapy drugs
`http://loinc.org`	LL1128-9	PhenX07_19_pain med type
`http://loinc.org`	LL1129-7	PhenX07_20_pain med use
`http://loinc.org`	LL1130-5	PhenX07_21_pain med tabs/W
`http://loinc.org`	LL1131-3	PhenX07_22_stop pain meds
`http://loinc.org`	LL113-2	CR_1550_Radiation treatment location
`http://loinc.org`	LL1132-1	PhenX07_23_stop pain med reason
`http://loinc.org`	LL1133-9	PhenX07_24_use steroids/statins
`http://loinc.org`	LL1134-7	PhenX08_01_baby to bed with bottle
`http://loinc.org`	LL1135-4	PhenX08_02_add items to baby bottle
`http://loinc.org`	LL1136-2	PhenX08_03_breast feeding duration
`http://loinc.org`	LL1137-0	PhenX08_04_beverage consumed type
`http://loinc.org`	LL1138-8	PhenX08_05_cow milk type
`http://loinc.org`	LL1139-6	PhenX08_06_child beverage container
`http://loinc.org`	LL114-0	CR_1560_Radiation intent
`http://loinc.org`	LL1140-4	PhenX08_07_child beverage at meals
`http://loinc.org`	LL1141-2	PhenX08_08_child beverage between meals
`http://loinc.org`	LL1142-0	PhenX08_09_child night feedings
`http://loinc.org`	LL1143-8	PhenX08_10_mouth saliva amt
`http://loinc.org`	LL1144-6	PhenX08_11
`http://loinc.org`	LL1145-3	PhenX08_12_cleft lip dx
`http://loinc.org`	LL1146-1	PhenX08_13_cleft lip code
`http://loinc.org`	LL1147-9	PhenX08_14_teeth braces duration
`http://loinc.org`	LL1148-7	PhenX08_15_natural teeth amt
`http://loinc.org`	LL1149-5	PhenX08_16_brush teeth freq
`http://loinc.org`	LL1150-3	PhenX08_17-dental floss freq
`http://loinc.org`	LL1151-1	PhenX08_18_tooth surface index flourosis
`http://loinc.org`	LL1152-9	PhenX08_19_ last dentist visit
`http://loinc.org`	LL1153-7	PhenX08_20_dentist visit reason
`http://loinc.org`	LL1154-5	PhenX08_21_pain duration
`http://loinc.org`	LL1155-2	PhenX09_01
`http://loinc.org`	LL1156-0	Mild\|Moderate\|Severe
`http://loinc.org`	LL115-7	CR_1570_Radiation modality
`http://loinc.org`	LL1158-6	PhenX09_04- smoking inhalation
`http://loinc.org`	LL1159-4	PhenX09_05_inhale pipe,cigars
`http://loinc.org`	LL1162-8	Quantity (5 answers, ord)
`http://loinc.org`	LL1163-6	PhenX06_32_UV exposure times
`http://loinc.org`	LL116-5	CR_1580_Radiation completion
`http://loinc.org`	LL1165-1	PhenX07_26_Mos exercise freq
`http://loinc.org`	LL1166-9	PhenX07_27_age range CA relative
`http://loinc.org`	LL1167-7	PhenX07_28_first CA dx
`http://loinc.org`	LL1168-5	PhenX07_29_2nd CA dx
`http://loinc.org`	LL1171-9	PhenX09_10_wheezing freq
`http://loinc.org`	LL1172-7	PhenX09_11_noise interfere w/ activities
`http://loinc.org`	LL117-3	CR_1590_Radiation outcome
`http://loinc.org`	LL1173-5	PhenX09_12_wheezing amt
`http://loinc.org`	LL1174-3	PhenX09_13_first age rash
`http://loinc.org`	LL1175-0	PhenX09_14_itchy rash awakens freq
`http://loinc.org`	LL1176-8	PhenX09_15_health self assess
`http://loinc.org`	LL1177-6	PhenX09_16_resp probs freq
`http://loinc.org`	LL1178-4	PhenX09_17_attacks of chest trouble amt
`http://loinc.org`	LL1179-2	PhenX09_18_last worst chest attack
`http://loinc.org`	LL11-8	MDS_399_Memory
`http://loinc.org`	LL1180-0	PhenX09_19_ good chest days
`http://loinc.org`	LL1181-8	PhenX09_20_chest trouble at work
`http://loinc.org`	LL1182-6	PhenX09_21
`http://loinc.org`	LL1183-4	PhenX09_22_how chest prob affects you
`http://loinc.org`	LL1184-2	PhenX09_23_snoring loudness
`http://loinc.org`	LL1185-9	PhenX09_24_snoring freq
`http://loinc.org`	LL1186-7	PhenX09_25_race/ethnicity
`http://loinc.org`	LL1187-5	PhenX09_26_spirometry data type
`http://loinc.org`	LL1188-3	PhenX09_27_FVC, FEV1 attribute
`http://loinc.org`	LL1189-1	PhenX09_28_review status
`http://loinc.org`	LL1190-9	PhenX10_01_pregnancy attempt services
`http://loinc.org`	LL1191-7	PhenX10_02_male infertility probs
`http://loinc.org`	LL1192-5	PhenX10_03_tubal ligation status
`http://loinc.org`	LL1193-3	PhenX10_04_vasectomy status
`http://loinc.org`	LL1194-1	PhenX10_05_Ys oral contraceptives
`http://loinc.org`	LL1195-8	PhenX10_06_birth control methods
`http://loinc.org`	LL1196-6	PhenX10_07_ age first period
`http://loinc.org`	LL1197-4	PhenX10_08_age full ht.
`http://loinc.org`	LL1198-2	PhenX10_09_hysterectomy
`http://loinc.org`	LL1199-0	PhenX10_10_male puberty peer comparison
`http://loinc.org`	LL1200-6	PhenX10_11_puberty status
`http://loinc.org`	LL1201-4	PhenX10_12_Mos nolvadex use
`http://loinc.org`	LL1202-2	PhenX10_13_evista nolvadex use
`http://loinc.org`	LL1203-0	PhenX10_14_Mos female hormone use
`http://loinc.org`	LL1204-8	PhenX10_15_combined hormone use
`http://loinc.org`	LL1205-5	PhenX10_16_ current estrogen type
`http://loinc.org`	LL1206-3	PhenX10_17_current progesterone type
`http://loinc.org`	LL120-7	CR_1642_Staging procedure
`http://loinc.org`	LL1207-1	PhenX10_18_oral conjugated estrogen dose
`http://loinc.org`	LL1208-9	PhenX10_19_Ds estrogen/progesterone
`http://loinc.org`	LL1209-7	PhenX10_20_HPV vaccination
`http://loinc.org`	LL1210-5	PhenX10_21_HPV shots amt
`http://loinc.org`	LL1211-3	PhenX10_22_male genitalia probs
`http://loinc.org`	LL1212-1	PhenX10_23_which testicle
`http://loinc.org`	LL1213-9	PhenX10_24_natural hormones
`http://loinc.org`	LL1214-7	PhenX10_25_tx undescended testicle
`http://loinc.org`	LL1215-4	PhenX10_26
`http://loinc.org`	LL1216-2	PhenX10_27_erection probs
`http://loinc.org`	LL1217-0	PhenX10_28_sexual probs
`http://loinc.org`	LL1218-8	PhenX10_29_maintain erection
`http://loinc.org`	LL1219-6	PhenX10_30_intercourse attempts
`http://loinc.org`	LL1220-4	PhenX10_31_intercourse enjoyment
`http://loinc.org`	LL1221-2	PhenX10_32_sexual stimulation
`http://loinc.org`	LL1222-0	PhenX10_33_sexual desire
`http://loinc.org`	LL1223-8	PhenX10_34_sexual satisfaction
`http://loinc.org`	LL1224-6	PhenX10_35_confidence to keep erection
`http://loinc.org`	LL1225-3	PhenX10_36_no periods >3Mos
`http://loinc.org`	LL1226-1	PhenX10_37_menstrual cycle pattern
`http://loinc.org`	LL1227-9	PhenX10_38_typical menstrual cycle
`http://loinc.org`	LL1228-7	PhenX10_39_periods stopped
`http://loinc.org`	LL1229-5	PhenX10_40_age periods stopped
`http://loinc.org`	LL1230-3	PhenX10_41_ night urination freq
`http://loinc.org`	LL1231-1	PhenX10_42_urination probs
`http://loinc.org`	LL1232-9	PhenX10_43_pregnancy outcome
`http://loinc.org`	LL1233-7	PhenX10_44_pregnancy nausea
`http://loinc.org`	LL1234-5	PhenX10_45_alcohol before/during pregnancy
`http://loinc.org`	LL1235-2	PhenX10_46_drinks during pregnancy
`http://loinc.org`	LL1236-0	PhenX10_47_this pregnancy outcome
`http://loinc.org`	LL1237-8	PhenX10_48_gender sexual attraction
`http://loinc.org`	LL1238-6	PhenX10_49_last same gender contact
`http://loinc.org`	LL1239-4	PhenX11_01_eye/reading probs
`http://loinc.org`	LL1240-2	PhenX11_02
`http://loinc.org`	LL1241-0	PhenX11_03_difficulty drawing,coloring
`http://loinc.org`	LL1242-8	PhenX11_04_last eye exam
`http://loinc.org`	LL1243-6	PhenX11_05_which eye
`http://loinc.org`	LL1245-1	PhenX11_07_child strabismus tx
`http://loinc.org`	LL1246-9	PhenX11_08_myopia tx
`http://loinc.org`	LL1247-7	PhenX11_09
`http://loinc.org`	LL1248-5	PhenX11_10_glaucoma drops
`http://loinc.org`	LL124-9	CR_1646_Surgery site
`http://loinc.org`	LL1249-3	PhenX11_11
`http://loinc.org`	LL1250-1	PhenX11_12_sunlight protection
`http://loinc.org`	LL1251-9	PhenX11_13_bilateral eyesight
`http://loinc.org`	LL1252-7	PhenX11_14_diabetic retinopathy surg
`http://loinc.org`	LL1253-5	PhenX11_15
`http://loinc.org`	LL1254-3	PhenX11_16_driving
`http://loinc.org`	LL1255-0	PhenX11_17_ difficulty day driving
`http://loinc.org`	LL125-6	CR_1660
`http://loinc.org`	LL1256-8	PhenX11_18_reason not driving
`http://loinc.org`	LL1257-6	PhenX11_19
`http://loinc.org`	LL1258-4	PhenX11_20
`http://loinc.org`	LL1259-2	PhenX11_21_contact lens type
`http://loinc.org`	LL12-6	MDS_428_Decision of ADLs
`http://loinc.org`	LL1260-0	PhenX11_22_child glasses, contacts
`http://loinc.org`	LL1261-8	PhenX11_23
`http://loinc.org`	LL1262-6	PhenX11_24_glasses type
`http://loinc.org`	LL1267-5	PhenX11_29_eye fields photo
`http://loinc.org`	LL1269-1	PhenX12_01
`http://loinc.org`	LL1270-9	PhenX12_02
`http://loinc.org`	LL1271-7	PhenX12_03
`http://loinc.org`	LL127-2	CR_170_Race coding system
`http://loinc.org`	LL1272-5	PhenX12_04
`http://loinc.org`	LL1273-3	PhenX12_05_upset with self
`http://loinc.org`	LL1274-1	PhenX12_06
`http://loinc.org`	LL1275-8	PhenX12_07_ mania feeling today
`http://loinc.org`	LL1276-6	PhenX12_08_mania compared to others
`http://loinc.org`	LL1277-4	PhenX12_09_ impact of life highs
`http://loinc.org`	LL1278-2	PhenX12_10_others reaction to mania
`http://loinc.org`	LL1279-0	PhenX12_11_len of mania highs
`http://loinc.org`	LL1280-8	PhenX12_12
`http://loinc.org`	LL1281-6	PhenX12_13_depression length
`http://loinc.org`	LL1282-4	PhenX12_14_depresion freq
`http://loinc.org`	LL1283-2	PhenX12_15_deression wt. gain, loss
`http://loinc.org`	LL1284-0	PhenX12_depression trouble sleeping
`http://loinc.org`	LL1285-7	PhenX12_17_time to fall asleep
`http://loinc.org`	LL1286-5	PhenX12_18_sleep during night
`http://loinc.org`	LL1287-3	PhenX12_19_waking too early
`http://loinc.org`	LL1288-1	PhenX12_20_sleep too much
`http://loinc.org`	LL1289-9	PhenX12_21_feeling sad
`http://loinc.org`	LL1290-7	PhenX12_22_appetite past 7D
`http://loinc.org`	LL1291-5	PhenX12_23_increased appetite past 7D
`http://loinc.org`	LL1292-3	PhenX12_24_wt. decrease
`http://loinc.org`	LL1293-1	PhenX12_25_wt. increase
`http://loinc.org`	LL1294-9	PhenX12_26_concentration
`http://loinc.org`	LL1295-6	PhenX12_27_view of self
`http://loinc.org`	LL1296-4	PhenX12_28_death thoughts
`http://loinc.org`	LL1297-2	PhenX12_29_general interest
`http://loinc.org`	LL1298-0	PhenX12_30_energy level
`http://loinc.org`	LL1299-8	PhenX12_31_feeling slowed down
`http://loinc.org`	LL1300-4	PhenX12_32_restlessness
`http://loinc.org`	LL1302-0	PhenX12_35_D of control loss
`http://loinc.org`	LL1303-8	PhenX12_36
`http://loinc.org`	LL1304-6	PhenX12_37_missed mentrual periods
`http://loinc.org`	LL1305-3	PhenX12_38_rating source
`http://loinc.org`	LL130-6	CR_1760_Vital status follow up
`http://loinc.org`	LL1306-1	PhenX12_39_onset psych illness
`http://loinc.org`	LL1307-9	PhenX12_40_employment at onset
`http://loinc.org`	LL1308-7	PhenX12_41_brain disease
`http://loinc.org`	LL1309-5	PhenX12_42_family hx schizophrenia
`http://loinc.org`	LL1310-3	PhenX12_43_family hx other psych
`http://loinc.org`	LL1311-1	PhenX12_44
`http://loinc.org`	LL1312-9	PhenX12_45
`http://loinc.org`	LL1313-7	PhenX12_46_altered libido
`http://loinc.org`	LL131-4	CR_1770_Cancer status follow up
`http://loinc.org`	LL1314-5	PhenX12_47_ suicidal ideation
`http://loinc.org`	LL1315-2	PhenX12_48_wt. loss amt
`http://loinc.org`	LL1316-0	PhenX12_49_wt. gain
`http://loinc.org`	LL1317-8	PhenX12_50_middle insomnia
`http://loinc.org`	LL1318-6	PhenX12_51
`http://loinc.org`	LL1319-4	PhenX12_52
`http://loinc.org`	LL1320-2	PhenX12_53_delusion screen
`http://loinc.org`	LL1321-0	PhenX02_04_body image subject
`http://loinc.org`	LL132-2	CR_1780_Survival quality
`http://loinc.org`	LL1322-8	PhenX02_05_body image scale
`http://loinc.org`	LL1323-6	PhenX02_06_body image shape
`http://loinc.org`	LL1324-4	PhenX12_54_delusions guilt presence
`http://loinc.org`	LL1325-1	PhenX12_55_poverty delusions presence
`http://loinc.org`	LL1326-9	PhenX12_56_nihilistic delusions presence
`http://loinc.org`	LL1328-5	PhenX12_58_illness insight
`http://loinc.org`	LL1329-3	PhenX12_59_affective psych symptoms
`http://loinc.org`	LL133-0	CR_1790_Follow up source
`http://loinc.org`	LL1330-1	PhenX12_60_response antipsychotic meds
`http://loinc.org`	LL1331-9	PhenX12_61_impairment incapacity
`http://loinc.org`	LL1332-7	PhenX12_62_deterioration fr premorbid level
`http://loinc.org`	LL1333-5	PhenX12_63_course of disorder
`http://loinc.org`	LL1334-3	PhenX12_64_rapport
`http://loinc.org`	LL1335-0	PhenX12_65_info credibility
`http://loinc.org`	LL1336-8	PhenX12_66
`http://loinc.org`	LL1337-6	PhenX12_67_job schedule
`http://loinc.org`	LL1338-4	PhenX12_68_job shift
`http://loinc.org`	LL13-4	MDS_439_Delirium indicators
`http://loinc.org`	LL1340-0	PhenX12_70
`http://loinc.org`	LL1341-8	PhenX12_71
`http://loinc.org`	LL1342-6	PhenX12_72_adapt to 3H sleep loss
`http://loinc.org`	LL1343-4	PhenX12_73_sleep loss affect mood, work
`http://loinc.org`	LL1344-2	PhenX12_74_sleep loss affect irritability,eating
`http://loinc.org`	LL1345-9	PhenX12_75_sleep loss recovery
`http://loinc.org`	LL1346-7	PhenX12_76_feel off no sleep
`http://loinc.org`	LL1347-5	PhenX12_77_jet lag return normal
`http://loinc.org`	LL1348-3	PhenX12_78_morning, evening person
`http://loinc.org`	LL1349-1	PhenX12_79_morning, evening preference
`http://loinc.org`	LL1350-9	PhenX12_80_sleepier than others
`http://loinc.org`	LL1351-7	PhenX12_81_movement during night
`http://loinc.org`	LL1352-5	PhenX12_82
`http://loinc.org`	LL1353-3	PhenX03_01_alcohol responses
`http://loinc.org`	LL1354-1	PhenX03_02_current cig smoking
`http://loinc.org`	LL135-5	CR_1800_Next follow up
`http://loinc.org`	LL1355-8	PhenX03_03_30d smoke freq
`http://loinc.org`	LL1356-6	PhenX03_04_30d smoke quant
`http://loinc.org`	LL1357-4	PhenX03_05_smoke cessation
`http://loinc.org`	LL1360-8	PhenX03_08_when give up smoking
`http://loinc.org`	LL1361-6	PhenX03_09_refrain from smoking difficulty
`http://loinc.org`	LL1362-4	PhenX12_83
`http://loinc.org`	LL1363-2	PhenX12_84
`http://loinc.org`	LL1364-0	PhenX12_85
`http://loinc.org`	LL1365-7	PhenX12_86
`http://loinc.org`	LL1366-5	PhenX13_01_speech, Parkinson's
`http://loinc.org`	LL1367-3	PhenX13_02_facil expression
`http://loinc.org`	LL1375-6	PhenX13_10_sensory symptoms
`http://loinc.org`	LL1376-4	PhenX13_11_ motor symptoms
`http://loinc.org`	LL1377-2	PhenX13_12_motor symptoms, arms
`http://loinc.org`	LL1378-0	PhenX13_13
`http://loinc.org`	LL1379-8	PhenX13_14_strength, legs
`http://loinc.org`	LL1380-6	PhenX13_15_strength, arms
`http://loinc.org`	LL1381-4	PhenX13_16_ulnar CMAP
`http://loinc.org`	LL1382-2	PhenX13_17_ulnar CMAP median
`http://loinc.org`	LL1383-0	PhenX13_18_ulnar SNAP
`http://loinc.org`	LL1384-8	PhenX13_19_ulnar SNAP median
`http://loinc.org`	LL1385-5	PhenX13_20_speech change
`http://loinc.org`	LL1386-3	PhenX13_21_visual disturbance
`http://loinc.org`	LL1387-1	PhenX13_22_affected side
`http://loinc.org`	LL138-9	CR_1840_Country
`http://loinc.org`	LL1389-7	PhenX13_24_trouble seeing
`http://loinc.org`	LL1390-5	PhenX13_25_sensation spread
`http://loinc.org`	LL1391-3	PhenX13_26
`http://loinc.org`	LL1392-1	PhenX13_27_headache complications
`http://loinc.org`	LL1393-9	PhenX13_28_headache pain
`http://loinc.org`	LL1394-7	PhenX13_29_headache affects
`http://loinc.org`	LL1395-4	PhenX13_30_inability to work amt
`http://loinc.org`	LL1396-2	PhenX13_31_usual headache treatment
`http://loinc.org`	LL1397-0	PhenX13_32_other daily meds
`http://loinc.org`	LL1398-8	PhenX13_33_last took med range
`http://loinc.org`	LL1399-6	PhenX13_34_headache type
`http://loinc.org`	LL1400-2	PhenX13_35_loss of consciousness
`http://loinc.org`	LL1402-8	PhenX13_37
`http://loinc.org`	LL1403-6	PhenX14_01_autoimmune diseases
`http://loinc.org`	LL1404-4	PhenX14_02
`http://loinc.org`	LL1406-9	PhenX14_04_medication for diabetes
`http://loinc.org`	LL1409-3	PhenX14_07_assay exclusion criteria glucose
`http://loinc.org`	LL1410-1	PhenX14_08_assay exclusion criteria
`http://loinc.org`	LL141-3	CR_1871_Cancer recurrance site
`http://loinc.org`	LL1413-5	PhenX14_11_solution consumed
`http://loinc.org`	LL1414-3	PhenX14_12_lap lengths
`http://loinc.org`	LL1415-0	PhenX14_13_which hand
`http://loinc.org`	LL1416-8	PhenX14_14_reason not to squeeze hand
`http://loinc.org`	LL1417-6	PhenX14_15_balance test score
`http://loinc.org`	LL1418-4	PhenX14_16_reason test failed
`http://loinc.org`	LL1419-2	BM
`http://loinc.org`	LL14-2	MDS_464_Change in status
`http://loinc.org`	LL1420-0	ANA
`http://loinc.org`	LL1421-8	ANCA
`http://loinc.org`	LL1423-4	PhenX14_17_aids for walk
`http://loinc.org`	LL1424-2	PhenX14_18_4 meter walk
`http://loinc.org`	LL1425-9	PhenX14_19_3 meter walk
`http://loinc.org`	LL1428-3	PhenX14_22_days, start Monday
`http://loinc.org`	LL1429-1	PhenX14_23_days, start Sunday
`http://loinc.org`	LL1430-9	PhenX14_24_activity total Hs
`http://loinc.org`	LL1431-7	PhenX14_25_reason no actigraph
`http://loinc.org`	LL1432-5	PhenX14_26_reason no activity recorded
`http://loinc.org`	LL1433-3	PhenX14_27_diary completed
`http://loinc.org`	LL1434-1	PhenX14_28_difficulty standing 2H
`http://loinc.org`	LL1435-8	PhenX14_29_neighborhood housing
`http://loinc.org`	LL1436-6	Pos\|Neg\|Equiv\|Quantity insuff\|Not tested
`http://loinc.org`	LL1437-4	FecalEIA
`http://loinc.org`	LL1438-2	PhenX03_10_emot/psych problems
`http://loinc.org`	LL1439-0	PhenX03_11_alcohol withdraw probs
`http://loinc.org`	LL1440-8	PhenX03_12_health probs drinking
`http://loinc.org`	LL1441-6	PhenX03_13_marijuana use probs
`http://loinc.org`	LL1442-4	PhenX03_14_marijuana withdraw probs
`http://loinc.org`	LL1443-2	PhenX03_15_lifetime drug use type
`http://loinc.org`	LL1444-0	PhenX03_16_ drug use >30D
`http://loinc.org`	LL1445-7	PhenX03_17_drug withdraw probs
`http://loinc.org`	LL1446-5	PhenX03_18_lifetime/30D drug type
`http://loinc.org`	LL144-7	CR_1880_Cancer recurrence type
`http://loinc.org`	LL1447-3	PhenX03_19_1D smoke quant
`http://loinc.org`	LL1449-9	PhenX03_21_smoking status
`http://loinc.org`	LL1450-7	PhenX03_22_first daily smoke
`http://loinc.org`	LL1451-5	PhenX06_33_residences
`http://loinc.org`	LL1452-3	PhenX06_34_daily life exposure types
`http://loinc.org`	LL1453-1	PhenX06_35_jobs
`http://loinc.org`	LL1454-9	PhenX06_36_job shift schedule
`http://loinc.org`	LL1455-6	PhenX06_37_hobbies
`http://loinc.org`	LL1457-2	PhenX06_39_siblings
`http://loinc.org`	LL1458-0	PhenX06_40_day care/preschools
`http://loinc.org`	LL1459-8	PhenX06_41_vacuum dust contaminant
`http://loinc.org`	LL1460-6	PhenX06_42_air contaminant
`http://loinc.org`	LL1461-4	PhenX06_43_age range UV exposure
`http://loinc.org`	LL146-2	CR_190_Hispanic origin
`http://loinc.org`	LL1462-2	PhenX06_44_UV exposure type
`http://loinc.org`	LL1464-8	PhenX06_46_rugs/drapes cleaning place
`http://loinc.org`	LL1465-5	PhenX07_30_age range exercise
`http://loinc.org`	LL1466-3	PhenX07_31_exercise Hs
`http://loinc.org`	LL1467-1	PhenX07_32_phys activity past Y
`http://loinc.org`	LL1468-9	PhenX07_33_passive smoke exposure
`http://loinc.org`	LL1469-7	PhenX07_34_estrogen use
`http://loinc.org`	LL147-0	CR_1910_Cause of death
`http://loinc.org`	LL1471-3	PhenX07_36_estrogen use method
`http://loinc.org`	LL1472-1	PhenX07_37_age range first hormone use
`http://loinc.org`	LL1473-9	PhenX07_38_age range current hormone use
`http://loinc.org`	LL1474-7	PhenX07_39_ menopause cause
`http://loinc.org`	LL1475-4	PhenX07_40_pregnancy outcome
`http://loinc.org`	LL1476-2	PhenX07_41_pregnancies
`http://loinc.org`	LL1478-8	PhenX07_43_CA screening type
`http://loinc.org`	LL1479-6	PhenX07_44_ CA treatment type
`http://loinc.org`	LL1480-4	PhenX07_45_age range alcohol exposure
`http://loinc.org`	LL1481-2	PhenX08_22_tooth code caries
`http://loinc.org`	LL1482-0	PhenX08_23_tooth location
`http://loinc.org`	LL1483-8	PhenX08_24_tooth code flourosis
`http://loinc.org`	LL1484-6	PhenX08_25_tooth position
`http://loinc.org`	LL1485-3	PhenX08_26_tooth aspect
`http://loinc.org`	LL1486-1	PhenX08_27_tobacco usage type
`http://loinc.org`	LL1487-9	PhenX08_28_toothache occasion
`http://loinc.org`	LL148-8	CR_1920_ICD revision
`http://loinc.org`	LL1489-5	PhenX08_29_cleft lip defect location
`http://loinc.org`	LL1490-3	PhenX08_30_items added to babys milk
`http://loinc.org`	LL1491-1	PhenX08_31_cleft palate, presence, relative
`http://loinc.org`	LL1493-7	PhenX09_30_smoking type
`http://loinc.org`	LL1494-5	PhenX09_31_medications
`http://loinc.org`	LL149-6	CR_1930_Autopsy
`http://loinc.org`	LL1497-8	PhenX07_46_progesterone/progestin use
`http://loinc.org`	LL1498-6	STX
`http://loinc.org`	LL1499-4	PhenX09_32
`http://loinc.org`	LL1500-9	PhenX09_33_cold to chest
`http://loinc.org`	LL1501-7	CT&GC probe
`http://loinc.org`	LL1502-5	MDSv3_J1700A
`http://loinc.org`	LL1503-3	MDSv3_F0300v2
`http://loinc.org`	LL150-4	CR_1940_Place of death
`http://loinc.org`	LL1504-1	PhenX08_32_decayed filled tooth
`http://loinc.org`	LL1506-6	PhenX09_34_pre-bronch FEV attempts
`http://loinc.org`	LL1507-4	PhenX09_35_pre-bronch FVC attempts
`http://loinc.org`	LL1508-2	PhenX09_36_post-bronch FEV attempts
`http://loinc.org`	LL1509-0	PhenX09_37_post-bronch FVC attempts
`http://loinc.org`	LL1510-8	PhenX08_34_filled tooth surfaces index
`http://loinc.org`	LL1511-6	Hb types
`http://loinc.org`	LL151-2	CR_1980_ICD conversion
`http://loinc.org`	LL1513-2	PhenX10_50_breast stage
`http://loinc.org`	LL1514-0	PhenX10_51_pubic hair stage
`http://loinc.org`	LL1515-7	PhenX10_52_gential development stage
`http://loinc.org`	LL1516-5	PhenX10_53_physical development stage
`http://loinc.org`	LL1518-1	PhenX10_54_birth control methods
`http://loinc.org`	LL1519-9	PhenX09_38_testing position
`http://loinc.org`	LL152-0	CR_1981_Cancer case reviewed
`http://loinc.org`	LL1520-7	PhenX09_39_testing challenge respiratory
`http://loinc.org`	LL1521-5	PhenX10_55_sexual desire level
`http://loinc.org`	LL1522-3	PhenX11_31_past dry eyes
`http://loinc.org`	LL1523-1	PhenX11_33_measurements
`http://loinc.org`	LL1526-4	PhenX11_36_sunlight protection
`http://loinc.org`	LL1528-0	PhenX09_40_parent
`http://loinc.org`	LL1529-8	Phenx11_38_worry about eyesight
`http://loinc.org`	LL1530-6	PhenX10_56_eye problem
`http://loinc.org`	LL1532-2	VFC
`http://loinc.org`	LL1533-0	PhenX14_30_relative w/ diabetes
`http://loinc.org`	LL1534-8	PhenX14_31_diabetes problem
`http://loinc.org`	LL1536-3	PhenX12_87
`http://loinc.org`	LL1537-1	PhenX12_88
`http://loinc.org`	LL1538-9	PhenX12_89
`http://loinc.org`	LL1539-7	PhenX10_58_cigarettes before/during pregnancy
`http://loinc.org`	LL1540-5	Phenx11_39_child vision problem
`http://loinc.org`	LL1541-3	Phenx11_40_adult eye problem
`http://loinc.org`	LL1542-1	Phenx11_41_strabismus treatment
`http://loinc.org`	LL1544-7	Phenx11_43_ETDRS Visual Acuity Chart line
`http://loinc.org`	LL1545-4	Phenx11_44_sleep w/ contacts in
`http://loinc.org`	LL1546-2	Phenx11_45_cities
`http://loinc.org`	LL1547-0	PhenX09_41_activities make breathless
`http://loinc.org`	LL1548-8	Phenx11_46_Dr. reported child vision problem
`http://loinc.org`	LL1549-6	Phenx11_47_glaucoma treatment
`http://loinc.org`	LL1551-2	PhenX12_90_event w/ insomnia
`http://loinc.org`	LL1552-0	PhenX12_91_falling asleep problems
`http://loinc.org`	LL1553-8	PhenX13_39_chg in speech problems
`http://loinc.org`	LL1555-3	PhenX10_59
`http://loinc.org`	LL1557-9	PhenX10_61
`http://loinc.org`	LL1558-7	PhenX12_92_feelings freq past 30D
`http://loinc.org`	LL1559-5	Phenx11_48_overall health
`http://loinc.org`	LL1560-3	Phenx11_49_rate eyesight now
`http://loinc.org`	LL1561-1	Phenx11_78_numeric pain scale
`http://loinc.org`	LL1562-9	PhenX12_93_numeric distress, impairment scale
`http://loinc.org`	LL1563-7	PhenX13_40_eye vision affected
`http://loinc.org`	LL1564-5	PhenX13_41_loss of vision problems
`http://loinc.org`	LL1565-2	PhenX13_42_double vision problems
`http://loinc.org`	LL1566-0	PhenX13_43_body part
`http://loinc.org`	LL1567-8	PhenX13_44_tingling problems
`http://loinc.org`	LL1568-6	PhenX13_45_paralysis, weakness problems
`http://loinc.org`	LL1569-4	PhenX13_46_dizziness problems
`http://loinc.org`	LL1571-0	Dialysis service
`http://loinc.org`	LL1572-8	Profit/Nonprofit
`http://loinc.org`	LL1573-6	Draft\|Final
`http://loinc.org`	LL1574-4	Accepted\|Rejected
`http://loinc.org`	LL1575-1	PhenX09_42_child doesn't listen
`http://loinc.org`	LL1576-9	Sal_Serotype
`http://loinc.org`	LL1577-7	PhenX12_94_worried, anxious problems
`http://loinc.org`	LL1578-5	PhenX12_95_phobias
`http://loinc.org`	LL1579-3	PhenX12_96_social phobias
`http://loinc.org`	LL1580-1	PhenX12_97_agoraphobias
`http://loinc.org`	LL1581-9	PhenX12_98_panic attack problems
`http://loinc.org`	LL1582-7	PhenX12_99_life aspects
`http://loinc.org`	LL1583-5	PhenX12_100_mania behavior
`http://loinc.org`	LL1584-3	PhenX12_101_day type
`http://loinc.org`	LL1585-0	PhenX12_102_psych stressor present
`http://loinc.org`	LL1586-8	PhenX12_103_premorbid adjustment
`http://loinc.org`	LL1587-6	PhenX12_104_depression variation
`http://loinc.org`	LL1589-2	PhenX12_106_marital status
`http://loinc.org`	LL15-9	MDS_473_Hearing
`http://loinc.org`	LL1590-0	HSV/VZV
`http://loinc.org`	LL1592-6	PhenX13_48_motor function child 2-4Y
`http://loinc.org`	LL1593-4	PhenX13_49_motor function child 4-6Y
`http://loinc.org`	LL1594-2	PhenX13_50_motor function child 6-12Y
`http://loinc.org`	LL1595-9	Relatives
`http://loinc.org`	LL1596-7	PhenX13_51_injuries
`http://loinc.org`	LL1597-5	PhenX10_62_pregnancy prevention methods
`http://loinc.org`	LL1598-3	PhenX10_63_probs during pregnancy
`http://loinc.org`	LL1599-1	Phenx11_79
`http://loinc.org`	LL1600-7	PhenX15_01_day sequence
`http://loinc.org`	LL1602-3	PhenX15_03_situations w/ sitting
`http://loinc.org`	LL1603-1	PhenX15_04
`http://loinc.org`	LL1604-9	PhenX15_05_degree of confidence exercise
`http://loinc.org`	LL1605-6	PhenX15_06_exercise circumstances
`http://loinc.org`	LL1606-4	PhenX15_07
`http://loinc.org`	LL1607-2	PhenX09_43_PEFR attempts
`http://loinc.org`	LL1608-0	PhenX14_33_blood draws
`http://loinc.org`	LL1609-8	PhenX16_01_health problems
`http://loinc.org`	LL1610-6	N men serogroup
`http://loinc.org`	LL1612-2	PhenX14_34_assay exclusion criteria, serum insulin
`http://loinc.org`	LL1614-8	PhenX17_01_Kellgren-Lawrence score
`http://loinc.org`	LL1615-5	PhenX17_02_eczema scores
`http://loinc.org`	LL1616-3	PhenX17_03_eczema area affected
`http://loinc.org`	LL1617-1	PhenX17_04_skin types
`http://loinc.org`	LL1618-9	PhenX18_01_speak,read,write English
`http://loinc.org`	LL1619-7	PhenX18_02
`http://loinc.org`	LL1620-5	PhenX18_03
`http://loinc.org`	LL1621-3	PhenX18_04
`http://loinc.org`	LL1622-1	PhenX18_05
`http://loinc.org`	LL1623-9	PhenX18_06
`http://loinc.org`	LL1624-7	PhenX18_07
`http://loinc.org`	LL1625-4	PhenX18_08
`http://loinc.org`	LL1626-2	PhenX18_09
`http://loinc.org`	LL1627-0	PhenX18_10
`http://loinc.org`	LL1628-8	PhenX18_11_languages
`http://loinc.org`	LL162-9	CR_200_Computed ethnicity
`http://loinc.org`	LL1629-6	PhenX18_12_language-speak,think
`http://loinc.org`	LL1630-4	PhenX18_13_feelings in past few W
`http://loinc.org`	LL1631-2	PhenX18_14_feelings, emotions
`http://loinc.org`	LL1632-0	PhenX18_15_fracture confirmation source
`http://loinc.org`	LL1633-8	PhenX18_16_hip fracture location
`http://loinc.org`	LL1634-6	PhenX18_17_fracture treatment
`http://loinc.org`	LL1635-3	PhenX18_18_fracture circumstances
`http://loinc.org`	LL1636-1	PhenX18_19_trauma location
`http://loinc.org`	LL1637-9	PhenX18_20_time of fracture
`http://loinc.org`	LL1638-7	PhenX18_21_fracture circumstances
`http://loinc.org`	LL1639-5	PhenX18_22_fracture location detail
`http://loinc.org`	LL1640-3	PhenX18_23
`http://loinc.org`	LL1641-1	CircStatus
`http://loinc.org`	LL1642-9	PhenX16_02_medical devices
`http://loinc.org`	LL1643-7	PhenX14_35
`http://loinc.org`	LL1645-2	PhenX16_03_autoimmune disroder presence
`http://loinc.org`	LL1646-0	PhenX17_05
`http://loinc.org`	LL1647-8	PhenX17_06_psoriasis treatment
`http://loinc.org`	LL1648-6	PhenX17_07_psoriasis tx effective scale
`http://loinc.org`	LL1649-4	PhenX17_08_ number of moles
`http://loinc.org`	LL1650-2	PhenX17_09
`http://loinc.org`	LL1652-8	PhenX18_24_careers
`http://loinc.org`	LL1653-6	PhenX18_25_social closeness
`http://loinc.org`	LL1654-4	PhenX18_26_race, ethnicity
`http://loinc.org`	LL1655-1	PhenX19_01_gallbladder disease age range
`http://loinc.org`	LL1656-9	PhenX19_02_gallbladder pain area
`http://loinc.org`	LL1657-7	PhenX19_03_pain helped w/ movement
`http://loinc.org`	LL1658-5	PhenX19_04_Dr. reported pain cause
`http://loinc.org`	LL1659-3	PhenX19_05
`http://loinc.org`	LL1660-1	PhenX19_06_reason Dr. visit
`http://loinc.org`	LL1661-9	PhenX19_07_abstract purpose
`http://loinc.org`	LL1662-7	PhenX19_08_non-scannable items entered
`http://loinc.org`	LL1663-5	PhenX19_09_data retrieval completed
`http://loinc.org`	LL1664-3	PhenX19_10_colorectal evaulation disposition
`http://loinc.org`	LL1665-0	PhenX19_11_diagnostic procedures performed
`http://loinc.org`	LL1666-8	PhenX19_12_colorectal procedure type
`http://loinc.org`	LL1667-6	PhenX19_13_cecum visualization
`http://loinc.org`	LL1668-4	PhenX19_14_hyperplastic polyps
`http://loinc.org`	LL1669-2	PhenX19_15_adenoma description
`http://loinc.org`	LL16-7	MDS_519_Making self understood
`http://loinc.org`	LL1670-0	PhenX19_16_adenoma histology
`http://loinc.org`	LL1671-8	PhenX19_17_adenoma dysplasia
`http://loinc.org`	LL1672-6	PhenX19_18_diagnostic, staging procedure
`http://loinc.org`	LL1673-4	PhenX19_19_complication dx evaluation
`http://loinc.org`	LL1674-2	PhenX19_20_colorectal CA dx eval
`http://loinc.org`	LL1675-9	PhenX19_21_colorectal gross morphology
`http://loinc.org`	LL1676-7	PhenX19_22_primary CA report
`http://loinc.org`	LL1677-5	PhenX19_23_CA histopathology type
`http://loinc.org`	LL167-8	CR_2040_Histology reviewed
`http://loinc.org`	LL1678-3	PhenX19_24_CA histopathology grade
`http://loinc.org`	LL1679-1	PhenX19_25_adenoma procedure
`http://loinc.org`	LL1680-9	PhenX19_26_summary CA staging
`http://loinc.org`	LL1681-7	PhenX19_27_AJCC CA staging manual edition
`http://loinc.org`	LL1682-5	PhenX19_28_ CA tumor type
`http://loinc.org`	LL1683-3	PhenX19_29_CA lymph node presence
`http://loinc.org`	LL1684-1	PhenX19_30_CA metastasis presence
`http://loinc.org`	LL1686-6	PhenX19_32_Dukes scoring
`http://loinc.org`	LL1687-4	PhenX19_33_modified Dukes - Astler-Coller
`http://loinc.org`	LL1688-2	PhenX19_34_ICD-O-2 cancer - grade
`http://loinc.org`	LL1689-0	PhenX19_35_ICD-O-2 cancer - behavior
`http://loinc.org`	LL1690-8	PhenX19_36_polyp location
`http://loinc.org`	LL1691-6	PhenX19_37_reason for sigmoidoscopy
`http://loinc.org`	LL1692-4	PhenX19_38_GI conditions
`http://loinc.org`	LL1693-2	PhenX19_39_bleeding site
`http://loinc.org`	LL1694-0	PhenX19_40_date range Y
`http://loinc.org`	LL1695-7	PhenX19_41_frequency
`http://loinc.org`	LL1696-5	PhenX19_42_stomach pain, nausea freq
`http://loinc.org`	LL1697-3	PhenX20_01_ear tube presence
`http://loinc.org`	LL1698-1	PhenX20_02_ear, sinus problems had
`http://loinc.org`	LL1699-9	PhenX20_03_hear better in one ear
`http://loinc.org`	LL1700-5	PhenX20_04_ear comments
`http://loinc.org`	LL1701-3	PhenX20_05_ear tested first
`http://loinc.org`	LL1702-1	PhenX20_06_headphone type
`http://loinc.org`	LL1703-9	PhenX20_07_ear test mode
`http://loinc.org`	LL1704-7	PhenX20_08_Hertz for hearing test sequence
`http://loinc.org`	LL1705-4	PhenX20_09_frequncies for hearing test
`http://loinc.org`	LL1706-2	PhenX20_10_thresholds
`http://loinc.org`	LL1707-0	PhenX18_27_social relationships
`http://loinc.org`	LL1708-8	PhenX15_08_job activities past Y
`http://loinc.org`	LL1709-6	PhenX15_09_leisure activities
`http://loinc.org`	LL1710-4	PhenX20_11
`http://loinc.org`	LL1711-2	PhenX20_12
`http://loinc.org`	LL1712-0	PhenX19_43_pain type
`http://loinc.org`	LL1714-6	PhenX20_13
`http://loinc.org`	LL1715-3	PhenX20_14
`http://loinc.org`	LL1716-1	PhenX20_15_dizziness attack
`http://loinc.org`	LL1718-7	PhenX20_17_ear w/ hearing difficulty
`http://loinc.org`	LL1719-5	PhenX20_18_which ear
`http://loinc.org`	LL1720-3	PhenX20_19
`http://loinc.org`	LL1721-1	PhenX20_20_speaking volume
`http://loinc.org`	LL1722-9	PhenX20_21_speaking freq
`http://loinc.org`	LL1723-7	PhenX20_22_diffilculty development time
`http://loinc.org`	LL1724-5	PhenX20_23_hearing difficulty reason known
`http://loinc.org`	LL1725-2	PhenX20_24_ears
`http://loinc.org`	LL1726-0	PhenX20_25_ ear discharge
`http://loinc.org`	LL1727-8	PhenX20_26
`http://loinc.org`	LL1728-6	PhenX20_27_relative participation
`http://loinc.org`	LL1729-4	PhenX20_28_migraine freq
`http://loinc.org`	LL1730-2	PhenX20_29_painkiller freq
`http://loinc.org`	LL1731-0	PhenX16_04
`http://loinc.org`	LL1732-8	PhenX16_05
`http://loinc.org`	LL1733-6	PhenX16_06
`http://loinc.org`	LL1734-4	emm type
`http://loinc.org`	LL1735-1	FeedingType
`http://loinc.org`	LL1736-9	MaternalFactors
`http://loinc.org`	LL1737-7	Mycobacteria
`http://loinc.org`	LL1738-5	PhenX20_30_meds duration_aspirin, med duration
`http://loinc.org`	LL1739-3	PhenX20_31_shots per weapon
`http://loinc.org`	LL1740-1	PhenX20_32_ear protection freq
`http://loinc.org`	LL1741-9	PhenX20_33_ear protection
`http://loinc.org`	LL1742-7	PhenX20_34_loud sound exposure
`http://loinc.org`	LL1743-5	Rickettsia DNA
`http://loinc.org`	LL1744-3	PhenX20_35_hrs exposed
`http://loinc.org`	LL1745-0	PhenX20_36_white finger syndrome response
`http://loinc.org`	LL1746-8	PhenX20_37_noise type
`http://loinc.org`	LL1747-6	PhenX20_38_sunburn susceptability
`http://loinc.org`	LL1748-4	PhenX20_39_eye color
`http://loinc.org`	LL1749-2	PhenX20_40_avg cigarettes/day
`http://loinc.org`	LL17-5	MDS_529_Speech clarity
`http://loinc.org`	LL1750-0	PhenX20_41_avg drinks
`http://loinc.org`	LL175-1	CR_210_Computed ethnicity source
`http://loinc.org`	LL1751-8	PhenX21_01_parent education
`http://loinc.org`	LL1752-6	PhenX21_02_reason for experience
`http://loinc.org`	LL1753-4	PhenX21_03_personal treament response
`http://loinc.org`	LL1755-9	PhenX21_04_neighborhood attribute agreement
`http://loinc.org`	LL1756-7	PhenX21_05_neighbor response
`http://loinc.org`	LL1757-5	PhenX21_06_name generator
`http://loinc.org`	LL1758-3	PhenX21_07_person
`http://loinc.org`	LL1759-1	PhenX21_08_closeness
`http://loinc.org`	LL1760-9	PhenX21_09_contact frequency
`http://loinc.org`	LL1761-7	PhenX2_10_trust doctors
`http://loinc.org`	LL1762-5	PhenX21_11_person response
`http://loinc.org`	LL1763-3	PhenX21_12_person cause problems
`http://loinc.org`	LL1764-1	PhenX21_13_experience
`http://loinc.org`	LL1765-8	PhenX21_14_event effect
`http://loinc.org`	LL1766-6	PhenX16_07_main symptom
`http://loinc.org`	LL1767-4	PhenX16_08_working dx number
`http://loinc.org`	LL1768-2	PhenX16_09_working dx status
`http://loinc.org`	LL176-9	CR_2116_Morphology conversion method
`http://loinc.org`	LL1769-0	PhenX16_10_travel risk
`http://loinc.org`	LL1770-8	PhenX16_11_clinical setting
`http://loinc.org`	LL1771-6	PhenX16_12_pt type
`http://loinc.org`	LL1772-4	PhenX16_13-medical hx
`http://loinc.org`	LL1773-2	PhenX16_14_inflammatory disorders
`http://loinc.org`	LL1775-7	PhenX16_16_infectious diseases
`http://loinc.org`	LL1776-5	PhenX16_17_non infectious illnesses
`http://loinc.org`	LL177-7	CR_2120_SEER coding system
`http://loinc.org`	LL1777-3	PhenX16_18_doctor visits
`http://loinc.org`	LL1778-1	PhenX16_19_hospitaliztions
`http://loinc.org`	LL1779-9	PhenX17_10_leg stand attempt
`http://loinc.org`	LL1780-7	PhenX21_15_section generator
`http://loinc.org`	LL1781-5	PhenX20_42_weapon type
`http://loinc.org`	LL1788-0	NEMSIS_01_cardiac arrest
`http://loinc.org`	LL1789-8	NEMSIS_02_cardiac arrest etiology
`http://loinc.org`	LL1790-6	NEMSIS_03_reason resusc not attempted
`http://loinc.org`	LL1791-4	NEMSIS_04_AED prior
`http://loinc.org`	LL1792-2	NEMSIS_05_first rhythm
`http://loinc.org`	LL179-3	CR_2140_CoC coding system
`http://loinc.org`	LL1793-0	NEMSIS_06_ return circulation
`http://loinc.org`	LL1794-8	NEMSIS_07_CPR d/c
`http://loinc.org`	LL1795-5	NEMSIS_08_cardiac rhythm-dest
`http://loinc.org`	LL1796-3	NEMSIS_09_complaint per dispatch
`http://loinc.org`	LL1797-1	NEMSIS_10_EMD performed
`http://loinc.org`	LL1798-9	NEMSIS_11_pt disposition
`http://loinc.org`	LL1799-7	NEMSIS_12_transport method
`http://loinc.org`	LL1800-3	NEMSIS_Response and Transport mode to/from scene
`http://loinc.org`	LL1802-9	NEMSIS_15_destination reason
`http://loinc.org`	LL1803-7	NEMSIS_16_peds resusc tape
`http://loinc.org`	LL1804-5	NEMSIS_17_skin assessment
`http://loinc.org`	LL1805-2	NEMSIS_18_head assessment
`http://loinc.org`	LL1806-0	NEMSIS_19_face assessment
`http://loinc.org`	LL1807-8	NEMSIS_20_neck assessment
`http://loinc.org`	LL1808-6	NEMSIS_21_chest/lung assessment
`http://loinc.org`	LL1809-4	NEMSIS_22_heart assessment
`http://loinc.org`	LL1810-2	NEMSIS_23_abd assessment
`http://loinc.org`	LL1811-0	NEMSIS_24_pelvic/GU assessment
`http://loinc.org`	LL1812-8	NEMSIS_25_back/spine assessment
`http://loinc.org`	LL1813-6	NEMSIS_26_extremity assessment
`http://loinc.org`	LL1814-4	NEMSIS_27_eye assessment
`http://loinc.org`	LL1815-1	NEMSIS_28_mental status
`http://loinc.org`	LL1816-9	NEMSIS_29_neuro assessment
`http://loinc.org`	LL1817-7	NEMSIS_30_barriers to care
`http://loinc.org`	LL1818-5	NEMSIS_31_adv directive
`http://loinc.org`	LL181-9	CR_2180_Follow up expectation
`http://loinc.org`	LL1819-3	NEMSIS_32_alc/drug use
`http://loinc.org`	LL1820-1	NEMSIS_33_pregnancy
`http://loinc.org`	LL1821-9	NEMSIS_34_field triage criteria
`http://loinc.org`	LL1822-7	NEMSIS_35_inj risk factors
`http://loinc.org`	LL1823-5	NEMSIS_36_pt loc in vehicle
`http://loinc.org`	LL1824-3	NEMSIS_37_safety equipment
`http://loinc.org`	LL1825-0	NEMSIS_38_airbag deployment
`http://loinc.org`	LL1826-8	NEMSIS_39_response to meds/cond at destination
`http://loinc.org`	LL182-7	CR_2190_SEER record
`http://loinc.org`	LL1827-6	NEMSIS_40_med complication
`http://loinc.org`	LL1828-4	NEMSIS_41_ill/inj registry
`http://loinc.org`	LL1829-2	NEMSIS_42_blood/fluid exposure
`http://loinc.org`	LL18-3	MDS_539_Understand others
`http://loinc.org`	LL1831-8	NEMSIS_44_procedure complication
`http://loinc.org`	LL1832-6	NEMSIS_45_protocol used
`http://loinc.org`	LL1833-4	NEMSIS_46_age category
`http://loinc.org`	LL1834-2	NEMSIS_47_primary unit role
`http://loinc.org`	LL183-5	CR_220_Sex-gender
`http://loinc.org`	LL1835-9	NEMSIS_48_dispatch delay
`http://loinc.org`	LL1836-7	NEMSIS_49_response delay
`http://loinc.org`	LL1837-5	NEMSIS_50_scene delay
`http://loinc.org`	LL1838-3	NEMSIS_51_transport delay
`http://loinc.org`	LL1839-1	NEMSIS_52_turnaround delay
`http://loinc.org`	LL1841-7	NEMSIS_55_pts at scene
`http://loinc.org`	LL184-3	CR_230
`http://loinc.org`	LL1843-3	NEMSIS_57_triage status at scene
`http://loinc.org`	LL1845-8	NEMSIS_59_level of responsiveness
`http://loinc.org`	LL1846-6	NEMSIS_60_CVA scale interpretation
`http://loinc.org`	LL1847-4	NEMSIS_61_Stroke scale type
`http://loinc.org`	LL1848-2	NEMSIS_62_ contra for thrombolytic
`http://loinc.org`	LL1851-6	PhenX16_20_surgery number
`http://loinc.org`	LL1852-4	NEMSIS_65_GCS qualifier
`http://loinc.org`	LL1853-2	RickImp
`http://loinc.org`	LL1854-0	PhenX19_44_colorectal dx procedure
`http://loinc.org`	LL1855-7	PhenX16_21_lab, imaging sequence
`http://loinc.org`	LL1857-3	PhenX16_22_PT/OT sequence
`http://loinc.org`	LL1858-1	NEMSIS_71_CPR technique
`http://loinc.org`	LL1859-9	SpecType
`http://loinc.org`	LL1860-7	PhenX17_11_psoriasis spot color
`http://loinc.org`	LL1862-3	PhenX19_45_initial visit reason
`http://loinc.org`	LL1863-1	PhenX19_46_bowel prep
`http://loinc.org`	LL1864-9	PhenX19_47_disease hx
`http://loinc.org`	LL1865-6	PhenX19_48_autoimmune diseases
`http://loinc.org`	LL1867-2	NEMSIS_67_GCS verbal
`http://loinc.org`	LL186-8	CR_2310_military record
`http://loinc.org`	LL1868-0	NEMSIS_68_GCS motor
`http://loinc.org`	LL1869-8	NEMSIS_69_GCs eye
`http://loinc.org`	LL1871-4	Babesia
`http://loinc.org`	LL1872-2	FMQAI_01
`http://loinc.org`	LL1873-0	FMQAI_02_Access type
`http://loinc.org`	LL1874-8	FMQAI_03_self dialysis training
`http://loinc.org`	LL1875-5	FMQAI_04_Graft functioning
`http://loinc.org`	LL1876-3	NeuroQol_01
`http://loinc.org`	LL1877-1	NeuroQol_02
`http://loinc.org`	LL1878-9	NeuroQol_03
`http://loinc.org`	LL1879-7	NeuroQol_04
`http://loinc.org`	LL1881-3	NeuroQol_06
`http://loinc.org`	LL1882-1	NeuroQol_07
`http://loinc.org`	LL1884-7	FMQAI_05_Reason no transplant info given
`http://loinc.org`	LL1885-4	FMQAI_06_Graft-fistula maturity
`http://loinc.org`	LL1886-2	FMQAI_07_Dialysis tx site
`http://loinc.org`	LL1887-0	FMQAI_08_Donor status
`http://loinc.org`	LL1888-8	FMQAI_09_Self dialysis traning loc
`http://loinc.org`	LL1889-6	FMQAI_10_Dialysis at time of death
`http://loinc.org`	LL1890-4	FMQAI_11_Reason therapy disconintued
`http://loinc.org`	LL1891-2	FMQAI_12_Payment source
`http://loinc.org`	LL189-2	CR_2410_Referring institution
`http://loinc.org`	LL1892-0	ICD-9_ICD-10
`http://loinc.org`	LL1893-8	NEMSIS_73_med/surg ICD code
`http://loinc.org`	LL1894-6	RxNorm
`http://loinc.org`	LL1895-3	PhenX17_12
`http://loinc.org`	LL1896-1	PhenX17_13
`http://loinc.org`	LL1897-9	PhenX15_10
`http://loinc.org`	LL1898-7	PhenX15_11
`http://loinc.org`	LL1899-5	PhenX15_12_activity intensity
`http://loinc.org`	LL1-9	Gender_M/F
`http://loinc.org`	LL1901-9	FMQAI_15_Employment status
`http://loinc.org`	LL1902-7	FMQAI_16_Albumin lab method
`http://loinc.org`	LL1904-3	Neg\|Small\|Mod\|Large
`http://loinc.org`	LL1906-8	Enterovirus+Parechovirus RNA
`http://loinc.org`	LL1907-6	Pincer cell presence (ord)
`http://loinc.org`	LL1908-4	R/S/Resistance possible
`http://loinc.org`	LL1909-2	Reac/Non-reac/Indet/Invalid
`http://loinc.org`	LL19-1	MDS_554_Vision
`http://loinc.org`	LL1910-0	FMQAI_17_Place of death
`http://loinc.org`	LL1911-8	FMQAI_18_Reason medicare entitlement
`http://loinc.org`	LL1912-6	Airway support (nom)
`http://loinc.org`	LL1913-4	NEMSIS_78_impact on vehicle
`http://loinc.org`	LL1914-2	SAMSHA_01_sources of stress
`http://loinc.org`	LL1915-9	SAMSHA_02_reason fail to take meds
`http://loinc.org`	LL1916-7	SAMSHA_03_occupational status
`http://loinc.org`	LL1918-3	Endotracheal tube activity
`http://loinc.org`	LL1919-1	Artificial airway type
`http://loinc.org`	LL1921-7	Airway patency (nom)
`http://loinc.org`	LL1922-5	NEMSIS_75_EMS condition codes
`http://loinc.org`	LL1924-1	CARE_LTCH_A1050_Education level
`http://loinc.org`	LL1925-8	NEMSIS_76_CPR provider
`http://loinc.org`	LL192-6	CR_2440_Following registry hospital
`http://loinc.org`	LL1926-6	NEMSIS_77_cardiac arrest witness
`http://loinc.org`	LL1927-4	RAST
`http://loinc.org`	LL1928-2	vanA + vanB + vanC1 + vanC2
`http://loinc.org`	LL1929-0	FMQAI_19_Peds GFR method
`http://loinc.org`	LL1930-8	FMQAI_20_Adult GFR method
`http://loinc.org`	LL1931-6	CARE_H0400_Bowel continence
`http://loinc.org`	LL1932-4	Haemophilus influenzae
`http://loinc.org`	LL1933-2	CARE_A1810_LTCH_medical services
`http://loinc.org`	LL193-4	CR_2460_Physician ID
`http://loinc.org`	LL1934-0	CARE_LTCH-reason for assessment
`http://loinc.org`	LL1935-7	PhenX09_44_chest condition description
`http://loinc.org`	LL1937-3	Present\|Absent
`http://loinc.org`	LL1938-1	ESRD_citizenship status
`http://loinc.org`	LL1939-9	ESRD_dialysis time period
`http://loinc.org`	LL1940-7	ESRD_medicare enrollment status
`http://loinc.org`	LL1942-3	Death certificate_tobacco use
`http://loinc.org`	LL1943-1	Death certificate_pregnancy status
`http://loinc.org`	LL1944-9	Death certificate_manner of death
`http://loinc.org`	LL1945-6	Death certificate_certifier
`http://loinc.org`	LL1946-4	OPTIMAL_confidence
`http://loinc.org`	LL1947-2	OPTIMAL_difficulty
`http://loinc.org`	LL1948-0	NEMSIS_79_disaster cause
`http://loinc.org`	LL1949-8	NEMSIS_80_CMS service level
`http://loinc.org`	LL1950-6	NEMSIS_81_anatomic organ system
`http://loinc.org`	LL1951-4	NEMSIS_82_healthcare facility activation
`http://loinc.org`	LL1952-2	PhenX15_13_adult activity
`http://loinc.org`	LL1953-0	PhenX16_23_Autoimmune disease, family hx
`http://loinc.org`	LL1954-8	PhenX16_24_Booster sequence
`http://loinc.org`	LL1955-5	PhenX16_25_Booster type
`http://loinc.org`	LL1956-3	PhenX08_36_bleeding on probling
`http://loinc.org`	LL1957-1	PhenX15_14_physical activity comparison
`http://loinc.org`	LL1958-9	PhenX15_15_day segment
`http://loinc.org`	LL1959-7	PhenX17_14_death in hospitalization
`http://loinc.org`	LL1960-5	PhenX16_26_injected drugs
`http://loinc.org`	LL1961-3	PhenX16_27_travel related illness
`http://loinc.org`	LL1962-1	PhenX15_16_older adult activities
`http://loinc.org`	LL1963-9	PhenX15_17_sitting adolescent activities
`http://loinc.org`	LL1964-7	PhenX15_18
`http://loinc.org`	LL1965-4	PhenX15_19_trial attempt
`http://loinc.org`	LL1966-2	PhenX14_36_amount of dextrose consumed
`http://loinc.org`	LL1967-0	PhenX15_20_balance test
`http://loinc.org`	LL1970-4	PhenX15_21_stretch test
`http://loinc.org`	LL1971-2	Variant Assess
`http://loinc.org`	LL1972-0	Genetic Knowledge
`http://loinc.org`	LL1973-8	PhenX17_15_laterality
`http://loinc.org`	LL1974-6	NEMSIS_83_mech of injury
`http://loinc.org`	LL197-5	CR_250_Birthplace
`http://loinc.org`	LL1975-3	0\|1\|2\|3\|4\|5\|6
`http://loinc.org`	LL1976-1	0 - Low\|1 - Mod\|2 - High
`http://loinc.org`	LL1977-9	serovars
`http://loinc.org`	LL1980-3	Restriction enzyme
`http://loinc.org`	LL1986-0	CFTR gene
`http://loinc.org`	LL1996-9	HIV Ab
`http://loinc.org`	LL1997-7	PHQ_01
`http://loinc.org`	LL2001-7	NEMSIS_84_environ allergies
`http://loinc.org`	LL2003-3	OPTIMAL_Mobility aids
`http://loinc.org`	LL2005-8	English speaking
`http://loinc.org`	LL2006-6	Ethnicity - HHS Std
`http://loinc.org`	LL200-7	CR_290_Occupation source
`http://loinc.org`	LL2008-2	CARE_LTCH-Pt. conditions from record
`http://loinc.org`	LL2009-0	Pos\|Neg\|Equiv
`http://loinc.org`	LL2010-8	Pos\|Neg\|Borderline
`http://loinc.org`	LL2011-6	PAP model
`http://loinc.org`	LL2012-4	PAP name
`http://loinc.org`	LL2013-2	PAP class
`http://loinc.org`	LL2014-0	Wild type-Hetero-Homo
`http://loinc.org`	LL201-5	CR_30_Registry type
`http://loinc.org`	LL2015-7	CARE_A1970_Discharge return status
`http://loinc.org`	LL2016-5	CARE_A4_other acute units prior
`http://loinc.org`	LL2017-3	Reactive w indet (3 answers, ord)
`http://loinc.org`	LL2019-9	CARE_1_A1_Reason for assessment
`http://loinc.org`	LL2021-5	Pos\|Neg\|Invalid
`http://loinc.org`	LL2022-3	N meningitidis culture
`http://loinc.org`	LL202-3	CR_300_Industry source
`http://loinc.org`	LL2023-1	NIH Stroke Scale Interval
`http://loinc.org`	LL2024-9	NIHSS - level of consciousness
`http://loinc.org`	LL2025-6	NIHSS-LOC questions
`http://loinc.org`	LL2026-4	NIHSS-LOC commands
`http://loinc.org`	LL2027-2	NIHSS-best gaze
`http://loinc.org`	LL2028-0	NIHSS-visual
`http://loinc.org`	LL2029-8	NIHSS-facial palsy
`http://loinc.org`	LL2030-6	NIHSS-motor arm
`http://loinc.org`	LL203-1	CR_330_Occupation coding system
`http://loinc.org`	LL2031-4	NIHSS-motor leg
`http://loinc.org`	LL2032-2	NIHSS-limb ataxia
`http://loinc.org`	LL2033-0	NIHSS-sensory
`http://loinc.org`	LL2034-8	NIHSS-best language
`http://loinc.org`	LL2035-5	NIHSS-dysarthria
`http://loinc.org`	LL2036-3	NIHSS-extinction & inattention
`http://loinc.org`	LL2037-1	PTSD Checklist - PCL
`http://loinc.org`	LL2038-9	Pos\|Neg\|Indeterm
`http://loinc.org`	LL2039-7	Entamoeba sp
`http://loinc.org`	LL2040-5	Body Surface Area Methods-DICOM
`http://loinc.org`	LL2041-3	Malaria
`http://loinc.org`	LL2042-1	FACIT bone pain score (ord)
`http://loinc.org`	LL204-9	CR_3300_Rural-urban 1993
`http://loinc.org`	LL206-4	CR_35_FIN coding system
`http://loinc.org`	LL2067-8	RABV strain
`http://loinc.org`	LL2068-6	Cryptococcus sp
`http://loinc.org`	LL2069-4	No Diff \| A little Diff \| Some Diff \| Much Diff
`http://loinc.org`	LL2070-2	FACIT-TS-G- treatment choice
`http://loinc.org`	LL2071-0	FACIT-TS-G - treatment expectations
`http://loinc.org`	LL2072-8	FACIT-TS-G-treatment effects
`http://loinc.org`	LL2073-6	FACIT-TS-G-treatment rating
`http://loinc.org`	LL2074-4	FACIT-TS-G-visit rated
`http://loinc.org`	LL2075-1	FACIT-dyspnea -reason activity not done
`http://loinc.org`	LL2076-9	Edinburgh Postnatal Depression-1
`http://loinc.org`	LL2077-7	Edinburgh Postnatal Depression-2
`http://loinc.org`	LL2078-5	Edinburgh Postnatal Depression-3
`http://loinc.org`	LL2079-3	Edinburgh Postnatal Depression-4
`http://loinc.org`	LL208-0	CR_360_Fam hx of cancer
`http://loinc.org`	LL2080-1	Edinburgh Postnatal Depression-5
`http://loinc.org`	LL2081-9	Edinburgh Postnatal Depression-6
`http://loinc.org`	LL2082-7	Edinburgh Postnatal Depression-7
`http://loinc.org`	LL2083-5	Edinburgh Postnatal Depression-8
`http://loinc.org`	LL2084-3	Edinburgh Postnatal Depression-9
`http://loinc.org`	LL2085-0	Edinburgh Postnatal Depression-10
`http://loinc.org`	LL2087-6	FACIT-TS-PS-explanatons
`http://loinc.org`	LL2088-4	FACIT-TS-PS-trust
`http://loinc.org`	LL2089-2	None\|1+\|2+\|3+
`http://loinc.org`	LL20-9	MDS_579_Depression, anxiety, mood
`http://loinc.org`	LL2090-0	Leptospira sp
`http://loinc.org`	LL2091-8	Legionella sp
`http://loinc.org`	LL2093-4	Rotavirus
`http://loinc.org`	LL2094-2	NBS Hb

Explanation of the columns that may appear on this page:

Level

A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies

System

The source of the definition of the code (when the value set draws in codes defined elsewhere)

Code

The code (used as the code in the resource instance)

Display

The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application

Definition

An explanation of the meaning of the concept

Comments

Additional notes about how to use the code